Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 319,767	$ 139,036
Restricted cash	449	449
Prepaid expenses and other current assets	4,431	2,645
Total current assets	324,647	142,130
Restricted cash	2,315	2,151
Property, plant and equipment, net	6,736	7,485
Operating lease right-of-use assets	9,439	8,381
Other non-current assets	183	217
Total assets	343,320	160,364
Current liabilities
Accounts payable	6,275	3,592
Accrued expenses and other current liabilities	20,277	12,862
Deferred revenue		9,773
Total current liabilities	26,552	26,227
Term loan, net	50,106	43,942
Operating lease liability, net of current portion	18,172	17,361
Other non-current liabilities	1,552	1,309
Total liabilities	96,382	88,839
Commitments and contingencies - Note 13
Stockholders' equity
Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized and no shares issued and outstanding as of December 31, 2025 and December 31, 2024
Common stock, $0.00001 par value per share; 700,000,000 shares authorized and 285,051,648 issued and outstanding as of December 31, 2025 and 400,000,000 shares authorized and 204,943,306 issued and outstanding as of December 31, 2024	3	2
Additional paid-in capital	958,427	677,859
Accumulated other comprehensive loss	(192)	(4,031)
Accumulated deficit	(711,300)	(602,305)
Total stockholders’ equity	246,938	71,525
Total liabilities and stockholders' equity	$ 343,320	$ 160,364